高甘油三酯血症在动脉粥样硬化血栓性卒中患者中的预后作用
东京女子医科大学卒中登记研究为前瞻性观察性研究,连续纳入870例急性缺血性卒中或TIA患者并随访1年。高甘油三酯血症定义为空腹血清甘油三酯≥150 mg/dL。高甘油三酯血症与颅内动脉狭窄患病率增加相关,且主要心血管不良事件年发生率20.9% vs 9.7%(p<0.001),校正混杂因素后调整风险比2.46(95%CI 1.62-3.74)。在动脉粥样硬化血栓性卒中、颅内动脉狭窄及颈动脉颅外段狭窄患者中风险更高,而心源性栓塞卒中患者中无预测作用(p=0.18)。
要点
- 高甘油三酯血症与动脉粥样硬化血栓性卒中患者主要心血管不良事件风险升高相关,调整HR 2.46(95%CI 1.62-3.74)。
- 高甘油三酯血症与颅内动脉狭窄(尤其前循环)患病率增加相关,而非颅外动脉狭窄。
- 在心源性栓塞卒中患者中,高甘油三酯血症对复发性血管事件无预测作用(年发生率19.1% vs 10.5%,p=0.18)。
核心结论
- 高甘油三酯血症是动脉粥样硬化血栓性卒中患者残余血管风险的重要可干预危险因素,即使在接受他汀治疗的情况下亦然。
研究设计与样本
- 东京女子医科大学卒中登记研究为前瞻性观察性登记研究,连续纳入870例发病1周内的急性缺血性卒中或TIA患者,随访1年。
- 高甘油三酯血症定义为空腹血清甘油三酯≥150 mg/dL;显著颈脑血管狭窄定义为≥50%狭窄或闭塞。
- 主要结局为主要心血管不良事件,包括非致死性卒中、非致死性急性冠脉综合征和血管性死亡。
主要发现
- 870例患者平均年龄70.1岁,男性60.9%,217例(24.9%)存在高甘油三酯血症。
- 高甘油三酯血症患者主要心血管不良事件年发生率为20.9%,无高甘油三酯血症者为9.7%(p<0.001)。
- 校正包括基线低密度脂蛋白胆固醇和他汀使用在内的潜在混杂因素后,调整风险比为2.46(95%CI 1.62-3.74)。
- 在动脉粥样硬化血栓性卒中患者(n=174)中,高甘油三酯血症组年发生率35.1% vs 无高甘油三酯血症组14.2%(p=0.001)。
- 在显著颅内动脉狭窄患者(n=247)中,年发生率29.9% vs 14.7%(p=0.006);在显著颈动脉颅外段狭窄患者(n=123)中,年发生率23.0% vs 9.4%(p=0.042)。
关键数值与推荐
- 高甘油三酯血症定义为空腹血清甘油三酯≥150 mg/dL。
- 显著颈脑血管狭窄定义为≥50%狭窄或闭塞。
- 本研究提供I类证据表明,在动脉粥样硬化血栓性卒中患者中,高甘油三酯血症与主要心血管事件风险增加相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Hypertriglyceridemia is perceived to promote atherosclerotic pathology, but its role in stroke has not been well defined. Our aim was to assess the contribution of hypertriglyceridemia to residual vascular risk in patients with atherothrombotic stroke. METHODS: The Tokyo Women's Medical University Stroke Registry is an ongoing prospective, observational registry in which 870 patients with acute ischemic stroke or TIA within 1 week of onset were consecutively enrolled and followed up for 1 year. Hypertriglyceridemia was defined as serum triglycerides levels of ≥150 mg/dL under fasting conditions. Significant stenosis of the cervicocephalic arteries was defined as having ≥50% stenosis or occlusion. The primary outcome was major adverse cardiovascular events, including nonfatal stroke, nonfatal acute coronary syndrome, and vascular death. RESULTS: Of 870 patients (mean age 70.1 years, male 60.9%), 217 (24.9%) had hypertriglyceridemia. High triglycerides levels were significantly associated with an increased prevalence of intracranial artery stenosis, particularly in the anterior circulation, rather than extracranial artery stenosis. Patients with hypertriglyceridemia had a greater risk of major adverse cardiovascular events than those without (annual rate 20.9% vs 9.7%; p < 0.001), even after adjustment for potential confounders, including baseline low-density lipoprotein cholesterol and statin use (adjusted hazard ratio 2.46, 95% CI 1.62-3.74). The higher risk of vascular events in patients with hypertriglyceridemia vs without hypertriglyceridemia was observed among patients with stroke of atherothrombotic origin (n = 174, annual rate 35.1% vs 14.2%; p = 0.001), those with significant intracranial artery stenosis (n = 247, annual rate 29.9% vs 14.7%; p = 0.006), and those with significant extracranial carotid artery stenosis (n = 123, annual rate 23.0% vs 9.4%; p = 0.042). In contrast, hypertriglyceridemia was not predictive of recurrent vascular events in patients with cardioembolic stroke (n = 221, annual rate 19.1% vs 10.5%; p = 0.18). DISCUSSION: Hypertriglyceridemia is an important modifiable risk factor that drives residual vascular risk in patients with stroke of atherothrombotic origin, even while on statin therapy. TRIAL REGISTRATION INFORMATION: UMIN000031913 at upload.umin.ac.jp. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that in patients with atherothrombotic stroke, hypertriglyceridemia is associated with an increased risk of major cardiovascular events.
引用
- Hoshino T, Ishizuka K, Toi S, et al. Prognostic Role of Hypertriglyceridemia in Patients With Stroke of Atherothrombotic Origin. Neurology. 2022. PMID: 35296551. doi:10.1212/WNL.0000000000200112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。